694 results
Page 17 of 35
6-K
az8ewqqhz5gfve4 pjg
11 Apr 11
Teva Announces Presentation of New Data on Multiple Sclerosis and Parkinson???s Disease Treatments at 2011 American Academy of Neurology Annual Meeting
12:00am
6-K
khh97a32
7 Apr 11
Teva and Oncogenex Present Preclinical Data on the Activity of Its Antisense Compound Custirsen (OGX-011/TV-1011) at the American Association of Cancer Research (Aacr) Annual Meeting 2011
12:00am
6-K
f1fxol
24 Mar 11
the Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership
12:00am
6-K
k8ggv1yle 4q
17 Mar 11
Teva Announces Pricing of $750,000,000 of Senior Notes
12:00am
424B5
og8 9mtb1xa
17 Mar 11
Prospectus supplement for primary offering
12:00am
424B5
v3mjc
16 Mar 11
Prospectus supplement for primary offering
12:00am
6-K
ay7jntu o7
1 Mar 11
Teva Announces Trial Date In Generic Copaxone? Litigation
12:00am
6-K
nym79lbz7g99zrh6vi
9 Feb 11
Teva Announces Results from a Phase III Study for Qnaze??? Nasal Aerosol In Perennial Allergic Rhinitis
12:00am
6-K
EX-99.1
nfd zd4iu6
8 Feb 11
Teva Reports Full Year and Fourth Quarter 2010 Results
12:00am
6-K
df00q0qldugspwuf7yvt
8 Feb 11
Teva Provides 2011 Non-gaap Financial Outlook
12:00am
6-K
qt2zmk3
27 Jan 11
Teva to Acquire Corporaci?n Infarmasa
12:00am
6-K
niei5 5jp
26 Jan 11
Teva and App Announce Launch of Generic Gemzar?; Pursuant to Agreement
12:00am
6-K
9z58ej
25 Jan 11
Teva Enters into $1.5 Billion Syndicated Credit Facility
12:00am
6-K
tj5ubj806f
25 Jan 11
Teva Receives Fda Action Letter for Generic Lovenox?
12:00am
6-K
5z7cd
11 Jan 11
Teva Calls 1.75% Convertible Debentures Due 2026 for Redemption
12:00am
6-K
69q2k3vz3we4komz
10 Jan 11
Teva Provides Update on Venlafaxine HCL Er
12:00am
6-K
b5cc1qy0f7va6
5 Jan 11
Teva Completes Acquisition of Theramex
12:00am
6-K
1oi m1una
23 Dec 10
Teva and Takeda Settle Generic Actos? and Actoplus Met? Litigation
12:00am
6-K
c8nom
23 Dec 10
Fda Issues Complete Response Letter for Lower-volume Glatiramer Acetate Snda
12:00am